Jane Street
DMAQR

Jane Street’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Jane Street’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,818
Closed -$4K – 11254
2021
Q4 		$4K Buy
+11,818
New +$3.74K ﹤0.01% 9955

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Jane Street's DMAQR Position: Q1 2022 in Review

Jane Street sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2022, closing a stake of 11,818 shares — an estimated $4K sold.

Jane Street first reported a position in DMAQR in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 28 funds tracked by Wall St. Rank hold DMAQR as of Q1 2022.

  • Jane Street reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 11,818 Deep Medicine Acquisition Corp. Rights shares in Q1 2022, an estimated $4K.
  • Jane Street first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 1 quarter.
  • Jane Street's Deep Medicine Acquisition Corp. Rights position peaked at $4K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.